Study to Assess the Efficacy and Safety of Rifaximin Administered BID in the Treatment of Patients With Diarrhea-Associated Irritable Bowel Syndrome

This study has been completed.

Study NCT00269412 Information provided by Salix Pharmaceuticals

First Received: December 22, 2005 Last Updated: December 21, 2009 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	September 2008
Primary Completion Date:	August 2007 (Final data collection date for primary outcome measure)